1,891
Views
12
CrossRef citations to date
0
Altmetric
Articles

Real-Time US-CT fusion imaging for guidance of thermal ablation in of renal tumors invisible or poorly visible with US: results in 97 cases

ORCID Icon, ORCID Icon, , , , , , , , , ORCID Icon & show all
Pages 771-776 | Received 09 Mar 2021, Accepted 25 Apr 2021, Published online: 10 May 2021

References

  • Ginzburg S, Tomaszewski JJ, Kutikov A. Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy. Nat Rev Urol. 2017;14:669–682.
  • Filippiadis D, Mauri G, Marra P, et al. Percutaneous ablation techniques for renal cell carcinoma: current status and future trends. Int J Hyperth. 2019;36:21–30.
  • Thompson RH, Atwell T, Schmit G, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67(2):252–259.
  • Atwell TD, Schmit GD, Boorjian SA, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: Comparative local control and complications after radiofrequency ablation and cryoablation. Am J Roentgenol. 2013;200:461–466.
  • Buy X, Lang H, Garnon J, et al. Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Am J Roentgenol. 2013;201:1353–1361.
  • Sartori S, Mauri G, Tombesi P, et al. Ultrasound-guided percutaneous laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk. Int J Hyperth off J Eur Soc Hyperthermic Oncol North Am Hyperth Gr. 2018;35(1):19–25.
  • Mauri G, Mistretta FA, Bonomo G, et al. Long-term follow‐up outcomes after percutaneous us/ct‐guided radiofrequency ablation for ct1a‐b renal masses: Experience from single high‐volume referral center. Cancers (Basel). 2020;12(5):1183.
  • Krokidis ME, Orsi F, Katsanos K, et al. CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma. Cardiovasc Intervent Radiol. 2017;40:177–191.
  • Mauri G, Nicosia L, Varano GM, et al. Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation. Insights Imaging. 2017;8:357–363.
  • Mauri G, Solbiati L, Orsi F, et al. Thermal ablation of liver tumours: the crucial role of 3D imaging. Cardiovasc Intervent Radiol. 2020;43:1416–1417.
  • Wood BJ, Locklin JK, Viswanathan A, et al. Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J Vasc Interv Radiol. 2007;18:9–24.
  • Ward TJ, Goldman RE, Weintraub JL. Electromagnetic navigation with multimodality image fusion for image-guided percutaneous interventions. Tech Vasc Interv Radiol. 2013;16:177–181.
  • Mauri G, De Beni S, Forzoni L, et al. Virtual navigator automatic registration technology in abdominal application. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:5570–5574.
  • Mauri G. Expanding role of virtual navigation and fusion imaging in percutaneous biopsies and ablation. Abdom Imaging. 2015;40:3238–3239.
  • Liu F-Y, Yu X-L, Liang P, et al. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol. 2012;81:1455–1459.
  • Monfardini L, Gennaro N, Della Vigna P, et al. Cone-beam CT-assisted ablation of renal tumors: preliminary results. Cardiovasc Intervent Radiol. 2019;42(12):1718–1725.
  • Amalou H, Wood BJ. Multimodality fusion with MRI, CT, and ultrasound contrast for ablation of renal cell carcinoma. Case Rep Urol. 2012;2012:1–5.
  • Mauri G, Cova L, De Beni S, et al. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38:143–151.
  • Eisenberg JD, Gervais DA, Singh S, et al. Radiation exposure from CT-guided ablation of renal masses: effects on life expectancy. Am J Roentgenol. 2015;204:335–342.
  • Arellano RS, Garcia RG, Gervais D. a, et al. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum. Am J Roentgenol. 2009;193(6):1686–1690.
  • Silverman SG, Tuncali K, Morrison PR. MR Imaging-guided percutaneous tumor ablation. Acad Radiol. 2005;12:1100–1109.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273:241–260.
  • Monfardini L, Orsi F, Caserta R, et al. Ultrasound and cone beam CT fusion for liver ablation: technical note. Int J Hyperth. 2018;0:1–5.
  • Mauri G, Orsi F, Carriero S, et al. Image-guided thermal ablation as an alternative to surgery for papillary thyroid microcarcinoma: preliminary results of an italian experience. Front Endocrinol (Lausanne). 2021;11:1.
  • Lyrdal D, Andersson M, Hellström M, et al. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: clinical results and radiological evolution during follow-up. Acta Radiol. 2010;51(7):808–818.
  • Kim HJ, Park BK, Park JJ, et al. CT-guided radiofrequency ablation of T1a renal cell carcinoma in Korea: mid-term outcomes. Korean J Radiol. 2016;17(5):763–770.
  • Zagoria RJ, Traver MA, Werle DM, et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am J Roentgenol. 2007;189(2):429–436.
  • Long Y, Xu E, Zeng Q. 2020; Intra-procedural real-time ultrasound fusion imaging improves the therapeutic effect and safety of liver tumor ablation in difficult cases. Am J Cancer Res. 10:2174–2184.
  • Mauri G, Porazzi E, Cova L, et al. 2014; Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. (2)5:209–216.